Search

Now showing items 1-5 of 5

Benefit Of High-Dose Methylprednisolone In Comparison With Conventional-Dose Prednisolone During Remission Induction Therapy In Childhood Acute Lymphoblastic Leukemia For Long-Term Follow-Up

Yetgin, S; Tuncer, MA; Cetin, M; Gumruk, F; Yenicesu, I; Tunc, B; Oner, AF; Toksoy, H; Koc, A; Aslan, D; Ozyorek, E; Olcay, L; Atahan, L; Tuncbilek, ET; Gurgey, A (Nature Publishing Group, 2003)

Eight-year event-free survival (EFS) was evaluated in 205 patients with acute lymphoblastic leukemia (ALL), to consider the efficacy of high-dose methylprednisolone (HDMP) given during remission induction chemotherapy ...

Allogeneic Hematopoietic Sct For Adults Aml Using I.V. Bu In The Conditioning Regimen: Outcomes And Risk Factors For The Occurrence Of Hepatic Sinusoidal Obstructive Syndrome

Nagler, A.; Labopin, M.; Berger, R.; Bunjes, D.; Campos, A.; Socie, G.; Kroeger, N.; Goker, H.; Yakoub-Agha, I.; Shimoni, A.; Mohty, M.; Rocha, V. (Nature Publishing Group, 2014)

I.v. BU is frequently used in the conditioning regimen prior to allogeneic hematopoietic SCT (allo-HSCT); however, overall outcomes, incidence of hepatic sinusoidal obstructive syndrome (SOS) and its risk factors are not ...

Bacterial Infection Prevention After Hematopoietic Cell Transplantation

Engelhard, D.; Akova, M.; Boeckh, M. J.; Freifeld, A.; Sepkowitz, K.; Viscoli, C.; Wade, J.; Raad, I. (Nature Publishing Group, 2009)

Life-Threatening Neurological Complications after Bone Marrow Transplantation in Children

Uckan, D; Cetin, M; Yigitkanli, I; Tezcan, I; Tuncer, M; Karasimav, D; Oguz, KK; Topcu, M (Nature Publishing Group, 2005)

Neurological complications may occur in BMT recipients (11-59%), frequently contributing to morbidity or mortality. They are the main causes of death in 10-15%. Life-threatening neurological complications were seen in 11 ...

Successful Bone Marrow Transplantation in a Case Of Griscelli Disease which Presented in Accelerated Phase with Neurological Involvement

Tezcan, I; Sanal, O; Ersoy, F; Uckan, D; Kilic, S; Metin, A; Cetin, M; Akun, R; Oner, C; Tuncer, AM (Stockton Press, 1999)

Griscelli disease (GD) is a rare disorder characterized by pigment dilution, immunodeficiency and occurrence of accelerated phase consisting of hemophagocytosis, pancytopenia and neurological manifestations, Allogeneic BMT ...